NO955258L - Medisinsk anvendelse av enzymer - Google Patents

Medisinsk anvendelse av enzymer

Info

Publication number
NO955258L
NO955258L NO955258A NO955258A NO955258L NO 955258 L NO955258 L NO 955258L NO 955258 A NO955258 A NO 955258A NO 955258 A NO955258 A NO 955258A NO 955258 L NO955258 L NO 955258L
Authority
NO
Norway
Prior art keywords
enzymes
medical use
enzyme
cyclic nucleotide
nucleotide pathways
Prior art date
Application number
NO955258A
Other languages
English (en)
Other versions
NO955258D0 (no
Inventor
Tracey Lehanne Mynott
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO955258D0 publication Critical patent/NO955258D0/no
Publication of NO955258L publication Critical patent/NO955258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En enzymkomponent av enzymbland- ; ingen bromelain som er funnet å ha en virkning på reaksjonsveier for sykliske nukleotider. Enzymet, stengel-brome- | lainprotease, anvendes derfor ved be- handling av sykdommer og tilstander formidlet av syklisk nukleotid- reaksjonsveier.
NO955258A 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer NO955258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313188A GB9313188D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1994/001368 WO1995000169A1 (en) 1993-06-25 1994-06-24 Medical use of stem bromelain protease

Publications (2)

Publication Number Publication Date
NO955258D0 NO955258D0 (no) 1995-12-22
NO955258L true NO955258L (no) 1996-02-22

Family

ID=10737823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955258A NO955258L (no) 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer

Country Status (11)

Country Link
US (1) US5824305A (no)
EP (1) EP0713396A1 (no)
JP (1) JPH08511687A (no)
AU (1) AU681891B2 (no)
CA (1) CA2165787A1 (no)
FI (1) FI956178A (no)
GB (1) GB9313188D0 (no)
NO (1) NO955258L (no)
NZ (1) NZ267660A (no)
SG (1) SG42309A1 (no)
WO (1) WO1995000169A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
CN1252101A (zh) 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
CA2333252C (en) * 1998-07-15 2008-11-25 Ursapharm Arzneimittel Gmbh Use of bromelain proteases for inhibiting blood coagulation
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US8066991B2 (en) 2005-10-11 2011-11-29 Amano Enzyme Usa Co., Ltd. Enzyme inhibitors of PAI-1
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
CN108884453B (zh) 2016-01-31 2022-07-29 麦迪伍德有限公司 用于治疗伤口的清创组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
GB8821049D0 (en) * 1988-09-08 1988-10-05 Health Lab Service Board Method & composition for treatment & prevention of viral infections
CA2114122A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
NZ253748A (en) * 1992-06-30 1997-06-24 Cortecs Ltd Use of enzymes especially proteolytic enzymes in the management or treatment of diarrhoea

Also Published As

Publication number Publication date
AU681891B2 (en) 1997-09-11
CA2165787A1 (en) 1995-01-05
NZ267660A (en) 1997-05-26
GB9313188D0 (en) 1993-08-11
EP0713396A1 (en) 1996-05-29
US5824305A (en) 1998-10-20
AU7002794A (en) 1995-01-17
FI956178A0 (fi) 1995-12-21
FI956178A (fi) 1996-02-21
WO1995000169A1 (en) 1995-01-05
NO955258D0 (no) 1995-12-22
SG42309A1 (en) 1997-08-15
JPH08511687A (ja) 1996-12-10

Similar Documents

Publication Publication Date Title
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
NO961888L (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
NO20014046L (no) Gabapentinderivater for forhindring og behandling av visceral smerte
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
AU5325686A (en) Vectors and method for expression of human protein c activity
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
NO955258L (no) Medisinsk anvendelse av enzymer
DK0470136T3 (da) Terapeutisk middel
DK0688362T3 (da) Kloning og rekombinant fremstilling af vespidgiftenzymer, såsom phospholipase og hyaluronidase, og immunologiske terapier baseret derpå
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
ATE277943T1 (de) Trypsininhibitoren
NO965564L (no) Medisinsk anvendelse av bromelain
ATE315558T1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
GR3015924T3 (en) Catabolic enzymes for the induction of the tumour necrosis factor (TNF).
IL123001A0 (en) Analgesic from snake venom
AU3206297A (en) Composition and method for treating herpes simplex
DE60029948D1 (de) Verbesserte methode zur behandlung von säugetieren mit geändertes säugetierblut
DK0673425T3 (da) DNA kodning for chitin deacetylase
HUP0103660A2 (hu) Mikróbaeredetű hialuronsavbontó enzimet tartalmazó gyógyászati készítmény
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application